Abstract Previously, we demonstrated that A549, a human lung cancer cell line, could be adapted to the free radical nitric oxide (NO • ). NO
Introduction
Lung cancer is a leading cause of death worldwide [1] . In the USA, the American Cancer Society's most recent statistics (2010) estimated that 222,520 people were diagnosed with lung cancer, and there were 157,300 deaths from this disease [2] . It has been shown that reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a key role in human cancer development [3] [4] [5] [6] [7] [8] .
ROS is a collective term that includes both oxygen radicals and certain non-radicals, such as hydrogen peroxide (H 2 O 2 ), which can spontaneously break down into oxygen radicals. RNS is also a collective term that includes nitric oxide radical (NO • ) and nitrogen dioxide radical (NO 2 • ), as well as other nitrogen-based non-radicals which can break down into nitrogen radicals [9] . Major sources of ROS/RNS include the endogenous aerobic metabolism within cells and/or cells exposed to ROS/RNS from various exogenous sources. Almost all normal cell types within the body have been shown to produce both ROS and RNS. These are produced at very low levels and are associated with normal cell functions. Additionally, ROS/RNS play important roles in many biological processes, including serving as intracellular signaling molecules and growth stimulators [10, 11] . The production of ROS/RNS at different levels can be either beneficial or harmful to the cells. Low concentrations of ROS/RNS have been shown to be beneficial for cells by altering mitogenic signals, activating transcription factors, and inducing apoptosis [12, 13] . On the other hand, elevated levels of ROS/RNS have been shown to be harmful for cells and is associated with initiation of cancer [10] . Excessive amounts of ROS/RNS can cause structural alterations in DNA, affect cytoplasmic and nuclear signal transduction pathways [14, 15] , and modulate the activity of the proteins and genes that respond to stress; these changes induced by excessive ROS/RNS levels act to regulate the genes that are related to cell proliferation, differentiation, and apoptosis [4, [14] [15] [16] [17] .
In the human body, free radicals are formed by multiple chemical reactions. Oxidative phosphorylation, a mitochondrial process which generates ATP, is coupled with a reaction in which O 2 is reduced to H 2 O. It is not clear what species is directly responsible for each of the biological activities where ROS have been implicated; however, there is a significant amount of experimental data that supports the idea that exposing normal cells to increasing concentrations of H 2 O 2 results in carcinogenesis. It is known that H 2 O 2 is associated with DNA damage, mutations, and genetic instability [18] [19] [20] [21] [22] [23] ; H 2 O 2 -induced DNA damage has been shown to be mediated by • OH generated from H 2 O 2 (the Fenton reaction) [18, 20, 22] . Several studies have also demonstrated that H 2 O 2 can induce cell proliferation [14, 24, 25] , apoptosis resistance [26, 27] , increased angiogenesis [28, 29] , invasion, and metastasis [24, 30, 31] .
In a previous study, we adapted A549 (parent) cells to a nitrogen-based free radical, DETA-NONOate, which resulted in a new cell line A549-HNO [32] . In that study, we demonstrated that, in the presence of H 2 O 2 , A549-HNO cells tolerated a higher concentration of H 2 O 2 than the A549-parent cells. These initial results suggested that the A549-parent cell line could possibly be adapted to H 2 O 2 . However, it remained unclear as to whether cells adapted to H 2 O 2 would also be resistant to increased levels of NO • exposure. Herein we set out to adapt the A549-parent cells to an oxygen-based free radical rather than a nitrogen-based free radical.
Materials and methodology

Cell culture and cell lines
In this study, we used A549, a human lung adenocarcinoma cell line, which was purchased from American Type Culture Collection (Manassas, VA, USA). A549 was grown in RPMI-1640 media which contained 2 mM L-glutamine, 2.5 μg/mL amphotericin B solution, 100 μg/mL streptomycin, 100 U/mL penicillin, and 10% fetal calf serum inactivated at 56°C for 30 min. RPMI-1640 media and all components were purchased from Invitrogen (Carlsbad, CA, USA). The cell line was grown in a humidified incubator at 37°C and 5% CO 2 . All other reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated.
In previous work, we adapted A549 cells to DETANONOate to produce the cell line A549-HNO [32] ; A549-HNO cells were utilized in the studies reported herein and were maintained as previously described [32] .
Verification of adaptation end-point A549-parent and A549-HNO cells were seeded into 96-well plates and grown for 24 h to~70% confluency in normal media (without hydrogen peroxide). Cells were then exposed to media containing various concentrations (0-9.6 mM) of hydrogen peroxide. The plates were then incubated for 24 h, at which time a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St. Louis, MO, USA) cell proliferation/viability assay was performed. The media was removed, and 100 μL of 2 mg/mL of MTT in phosphate buffer saline (PBS) was added to each of the wells. Plates were incubated at 37°C for 5 h, and the MTT was removed. The remaining purple formazan crystals were dissolved in 100 μL of dimethyl sulfoxide (DMSO), and a SpectraMax® Plus 384 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA) was used to read the absorbance of each well at 540 nm.
Cell adaptation process
In this study, A549 (parent cell line) was adapted over a 70-day period using a 30% hydrogen peroxide solution to produce the A549-HHP cell line. Hydrogen peroxide stock solutions were prepared in sterilized water. They were subsequently sterilized using a 0.5-μm filter unit.
In order to begin the adaptation process, cells were seeded in a 25-cm³ cell culture flask. After cells reached 80% confluency, the old media was removed, and fresh media supplemented with 0.033 mM of hydrogen peroxide solution was added to the flask. The flask was placed in the incubator and grown at 37°C and 5% CO 2 . After 24 h, supplemented media was removed and fresh media without hydrogen peroxide solution was added to the flask. After cells reached 100% confluency, the cells were again treated with trypsin-EDTA and transferred to a flask containing fresh media without hydrogen peroxide. This process was repeated, with the concentration of hydrogen peroxide being increased with each subsequent passage, until the concentration of hydrogen peroxide reached a level of 2.4 mM. The amount by which the concentration increased with each passage ranged from 0.033-0.153 mM, with the end-point (2.4 mM) was reached. This end-point was chosen because this dose was found to kill 100% of the parent cells and the A549-HNO cells (see "Verification of adaptation end-point" above). By definition, cells capable of growing in a lethal dose of hydrogen peroxide are indicative of biological changes having taken place in the A549-HHP cells when compared to the A549-parent cell line. During the adaptation process, aliquots of the adapted cells were periodically cryopreserved.
The parent cell (A549) was grown in parallel using standard conditions. Fresh media was replenished every 2-3 days.
Photomicroscopy of tissue culture cells
Cells were seeded in 25-cm 3 flasks and grown to 80% confluency with (A549-HHP) or without (A549-parent) hydrogen peroxide. Cells were imaged using a Reichert Microstart IV microscope (Reichert, Inc., Depew, NY, USA) at ×200. Images were captured with Infinity X-32 C multimedia software (Immunera Corp., Ottawa, ON, Canada).
Hydrogen peroxide and DETA-NONOate challenge assays Figure 1 represents a diagram of how the A549-HHP and A549-HNO adapted cell lines were challenged to an oxygen-or nitrogen-based free radical.
A549-parent (media without NO • donor or hydrogen peroxide), A549-HNO adapted (media with DETANONOate but without hydrogen peroxide), and A549-HHP adapted cells (media without NO • donor or hydrogen peroxide) were seeded (100 μL) into 96-well plates and incubated overnight. The original media was removed and replaced by fresh media (no DETA-NONOate or hydrogen peroxide). Serial dilutions as described above were then carried out using 0.1 mL of 2400 uM DETA-NONOate solution. The cells were then incubated at 37°C for an additional 72 h, after which time MTT assays were used to measure cell viability of the parent, HNO adapted, and HHP adapted cell lines as described above. (The A549-HNO cells were not maintained in DETA-NONOate media, nor were the A549-HHP cells maintained in hydrogen peroxide.) The same procedure was repeated, but with the donors being reversed for each cell line. The assays were repeated three times to validate the tolerated concentrations for parent and adapted cell lines. Individual trials were normalized, averaged, and the standard deviation was determined.
Growth assays
The MTT assay was used to measure cell proliferation/ viability of the parent and HHP adapted cells. A549-parent and A549-HHP adapted cells were seeded into 96-well microtiter plates. The cells were counted (2,000 cells/well) for each of the cell lines and an identical amount of cells was added to each well at the zero time point. The parent cell line was seeded and grown in the presence of RPMI-1640 media formulation, and HHP adapted cells were seeded and grown in RPMI-1640 media only, or media containing 2.4 mM hydrogen peroxide solution. MTT assays were carried out at the desired time points (24, 48 , or 72 h after seeding in the plates). R e s i s t a n c e above. Following overnight incubation and replenishment of media, serial dilutions were carried out using 0.1 mL of 6.24 μΜ doxorubicin solution (dissolved in DMSO). MTT assays were carried out 48 h after exposure to doxorubicin.
Gene chip assay
A comparative analysis of A549-parent cells and A549-HHP adapted cells was conducted using a "QuantArray 3.0" (PerkinElmer, Boston, MA, USA) system. Data was collected and analyzed using a R 2.9 Windows-compatible platform and the statistical analytic package "Limma 2.16" [33] . Background correction was conducted consistent with other efforts [34] using "Normexp" background correction methodology, with an "Offset" threshold value of 50. Background correction was performed with weights of control spots positioned at 0. Normalization was achieved by using "loess" and "scale" methods of "Normalize Within Arrays" and "Normalize Between Arrays" for within-array and between-array methodologies, respectively. Details of processes used may be found in [35] . "QuantArray" was used to control quality levels, with only those spots found acceptable by the software being included for signal transformations. Finally, normalized signals were used to determine the importance of differentiated expression levels with the use of linear modeling systems through "lmFit" and Bayes statistics achieved with the use of "eBayes" and "topTable," as previously utilized [36] .
Quantitative PCR analysis of mtDNA content
To generate the standard curves to quantitate the absolute amount of mtDNA in the tumor cell lines, one region of NADH dehydrogenase subunit 1 (ND1) gene and one region of β-actin (ACTB) gene were cloned using the pGEM®-T Easy Vector Systems (Promega, WI, USA) according to the manufacturer's recommendation. Table 1 lists the primers used to amplify the NADH dehydrogenase, subunit 1 (ND1) gene and β-actin (ACTB) gene using a 7500 Real Time PCR system (Applied Biosystems, Foster City, CA, USA). A 15-μL reaction mixture containing 1-5 ng of DNA template, 7.5 μL of SYBR Green PCR Master Mix (Applied Biosystems), and 25 pmol of each primer was amplified for 40 cycles. Each cycle consisted of a 10-min initial denaturation at 95°C, followed by 15-s denaturation at 95°C and 1-min annealing/ extension at 60°C. For each qPCR experiment, separate standard curves were generated from 10 serially diluted plasmids stocks (pGEM®-T Easy Vector Systems; Promega) containing either mtDNA ND1 or β-actin gene fragment. To calculate the absolute mtDNA copy number of the ND1 region in each sample, the amount of ND1 was normalized against the β-actin gene. Three independent experiments were run in triplicate, and a non-template control was also included in each experiment.
Data analysis and statistics
For each MTT experiment reported herein, at least three independent experiments were conducted and a representative example is shown in the "Results" section. A minimum of four wells were run in each experiment. All values that were more than two standard deviations from the mean were not included in the final analysis of the independent experiment values, and were normalized with respect to each other and then averaged. The error bars reported represent one standard deviation from the averaged normalized mean of the reported trial.
For the quantitative PCR experiments, three independent experiments were conducted, and the reported results show the average for the three experiments ± one standard deviation. Two-tailed Student t test assuming equal variance were conducted; P<0.05 was considered statistically significant.
Data were graphed using SigmaPlot version 11.0 (Systat Software, Inc., Chicago, IL, USA).
Results
Verification of adaptation end-point
Prior to the adaptation of the A549-parent cells, a concentration curve was used to determine the lethal dose of hydrogen peroxide to these cells. This dose was arbitrarily chosen to be the adaptation end-point (see "Cell adaptation" section below). This process replicates our earlier work on HNO cell adaptation of A549-parent cells [32] . The HNO cells were found to have significantly altered cell biology without changing morphology, and therefore we hypothesized that this would also be the case for hydrogen peroxide. In the current study, 2.4 mM hydrogen peroxide was found to consistently kill all of the parent cells after 24-h exposure as well as the A549-HNO cells (Fig. 2) . Thus, 2.4 mM was selected as the target level to maintain the cells once they were adapted. A549-HHP cells were grown in media in which the hydrogen peroxide donor was removed and they proliferated like the parent cell line (data not shown).
The A549-parent cells were exposed in media containing 2.4 mM hydrogen peroxide without adaptation. As expected, the parent cells were not able to survive when placed directly into media containing 2.4 mM hydrogen peroxide (data not shown).
Cell adaptation A549 (parent cell line) was subjected to adaptation with hydrogen peroxide to produce A549-HHP (Fig. 3) . The tumor cells were passaged using trypsin-EDTA and added to a new flask which contained RPMI-1640 media only (i.e., no hydrogen peroxide was added at this time). After cells reached~80% confluency, the original media was removed and fresh media supplemented with 33 μM of hydrogen peroxide was added. In the hydrogen-peroxide-containing media, cell growth was slowed, but the cells ultimately recovered. Every 2-3 days, new media containing hydrogen peroxide was added to the flask. Upon reaching confluency, the cells were passaged and divided into two flasks: the original flask, maintained at the current concentration of hydrogen peroxide solution, and a second flask in which the concentration of hydrogen peroxide was increased by approximately 0.033 mM. (As shown in Fig. 3 , other concentration increments were sometimes employed, based on how fast the cells recovered from the previous increase of hydrogen peroxide.)
Each data point on the adaptation curve represents an increase in the concentration of fresh hydrogen peroxide added to the cells. As mentioned above, when cells were exposed to the next higher concentration of hydrogen peroxide, slower growth was observed, and typically, cell death-up to~60%-was observed 24 h later. Cells were able to recover soon after, and over a period of 3-5 days grew to confluency. When a significant amount of cell death (roughly 70% or higher) was observed, new media was replaced without hydrogen peroxide until the cells had recovered.
As shown in Fig. 3 , the A549-parent cell line was successfully adapted to the target end-point concentration. The cells have been subsequently maintained at this concentration for over 12 months. The half-life of hydrogen peroxide has been reported to be anywhere from several hours to several days in water [37] ; therefore, the periodic addition of hydrogen peroxide every 2-3 days resulted in a repetitive cycle of elevated transient hydrogen peroxide exposure.
Photomicroscopy of tissue culture cells
The A549-parent and the A549-HHP adapted cell lines showed no morphological differences, as seen in Fig. 4 . Figure 5 shows the respective growth curves for both the A549-parent and A549-HHP cells. While the A549-parent showed a robust growth rate over the 72 h measured, the A549-HHP in the presence of H 2 O 2 had an even greater growth rate over the same time period. When the A549-HHP Fig. 2 MTT results of the survival curve used to verify the end-point determination for A549-parent, A549-HNO, and A549-HHP cells were grown in media lacking H 2 O 2 , their growth rate was almost double that of the A549-parent cells.
Growth curve
Hydrogen peroxide and DETA-NONOate challenge assays
In order to determine if the A549-HHP and A549-HNO adapted cells were able to survive a high free radical environment generated by nitrogen-based and oxygenbased donors, A549-parent, A549-HHP, and A549-HNO adapted cells were exposed to varying levels of hydrogen peroxide or DETA-NONOate (Figs. 2 and 6 ). Dosedependent growth curves are shown in Fig. 2 (H 2 O 2 , oxygen-based donor) and Fig. 6 (DETA-NONOate, nitrogen-based donor). All three cell lines-A549-parent, A549-HHP, and A549-HNO-were killed at concentrations of 1200 μM DETA-NONOate. However, at concentrations of 600 μM and below, the A549-HNO cells exhibited greater viability than A549-HHP and A549-parental cells (Fig. 6 ). In addition, at concentrations of 2.4 mM of H 2 O 2 and below, the A549-HHP cells exhibited greater viability than A549-parent cells. When the cells were exposed to the hydrogen peroxide (Fig. 2) , all three cell lines were killed at concentrations of 4. 
Doxorubicin challenge assay
The A549-parent and A549-HHP cells were challenged to various concentrations of doxorubicin (Fig. 7) . Doxorubicin (also known as adriamycin) is a well-known and commonly used anthracycline known to produce free radicals [38] . Because the A549-HHP cell line, which was adapted to H 2 O 2 , was partially cross-resistant to DETA-NONate, it was hypothesized that it would also be partially crossresistant to chemotherapeutic agents that produce free radicals. As noted in Fig. 7 , the A549-HHP cell line showed a greater resistance to doxorubicin exposure than did the A549-parent cell line.
Gene chip assay
The comparison of the A549-parent to the A549-HHP cell line resulted in a total of 1,731 genes having a significant (more than a 50%) change in gene fold expression. Among these, 811 of the genes were up-regulated, and 920 were Table 2 provides a list of genes with the ten highest and ten lowest gene fold change values.
Quantitative PCR analysis of mtDNA content
Using quantitative PCR to measure the copy number of mtDNA, we found that the A549-HHP cells had about a 9-fold decrease in mtDNA, as shown in Fig. 8 .
Discussion
In previous work from our laboratory, we were able to adapt the A549 cell line to comparatively high levels of NO
• (A549-HNO). This level represented a lethal dose of the free radical NO
• to the parent cell line. We have subsequently shown that the A549-HNO cell line has a comparatively more aggressive phenotype, without a corresponding change of morphology [32] . Herein we questioned whether this adapted phenotypic change was specific to the NO • free radical, or if it could be induced by any free radical. To test the hypothesis that any free radical can induce this phenotypic change, we undertook a series of studies using an oxygen-based free radical donor (H 2 O 2 ), rather than a nitrogen-based free radical. Analogous to the previously reported study in which we adapted the A549 cell line to DETA-NONOate (NO • donor) [32] , we attempted to adapt the A549 cell line to H 2 O 2 . In our previous study, it was determined that 2.4 mM was a lethal concentration of H 2 O 2 to the A549-parent and A549-HNO cell lines; this result was repeated in this study for completeness. Therefore, we set out to adapt the A549-parent cell line to 2.4 mM H 2 O 2 . Over the course of about 70 days, we were able to incrementally increase the dose of H 2 O 2 in the A549 H 2 O 2 adapted culture (A549-HHP), successfully reaching the desired end-point (Fig. 3) .
As in our previously reported work, we noted the lack of a morphological change between parent cells (A549-parent) and cells adapted to lethal doses of the nitrogen-based donor DETA-NONOate (A549-HNO). After the adaptation to the lethal dose of H 2 O 2 , representative photomicrographs of both the A549-parent and A549-HHP cell line were prepared (Fig. 4) , and again, as in this study, no noted morphological changes were observed between the parent (A549-parent) and cells adapted to the oxygen-based donor H 2 O 2 (A549-HHP). This is consistent with the clinical observation of two patients presenting with morphologically identical pathology but having significantly different clinical responses. The lack of morphologic changes in part validates these adapted cell lines as a model system to study the biological differences between these two biochemically different cell types. We next set out to determine if the A549-HHP cell line, which was adapted to the oxygen-based free radical, would be more or less resistant to hydrogen peroxide than the A549-HNO (nitrogen-based free radical) adapted cell line. In previous work, we have shown that the A549-HNO cell line was not only more resistant DETA-NONOate but was also more resistant to hydrogen peroxide than the parent cell line. In Fig. 2 , we demonstrate that the A549-HHP cell line is more resistant to hydrogen peroxide than the A549-HNO cell line, and that both of these cell lines are more resistant to hydrogen peroxide than the parent cell line. The data in this study is similar to what we previously reported for the A549-HNO cell line in that the cells that were adapted to the respective free radicals were resistant to that specific free radical but were also significantly resistant to other free radicals [32] . The ten most up-regulated genes, based upon fold changes, appear first, and the ten most down-regulated appear below within the A549 cell line types Fig. 7 MTT assay results for A549-parent and A549-HHP when challenged to varying concentrations of doxorubicin
The growth rates of the A549-HHP cells in media with and without H 2 O 2 were greater than the A549-parent cell line (see Fig. 5 ). The growth properties that were noted for the H 2 O 2 cells were similar to the NO
• adapted A549-HNO cells as previously reported [32] , in that the adapted cells grew faster than the parent cells. Combining the previous findings and the data reported herein, we have demonstrated that both nitrogen-and oxygen-based free radicals can result in phenotypic changes with increased growth rates. We hypothesized that the A549-HHP cell line, which was adapted to H 2 O 2 , would exhibit more resistance to DETA-NONOate than the parent A549 cell line, but not as much as the A549-HNO (see Fig. 1 ). Figures 2 and 6 show the results which demonstrate this cross-resistant relationship. This finding supports the concept that a given free radical, regardless of being an oxygen-or nitrogen-based free radical, can induce resistance to other free radicals. This is important clinically because both radiation and many chemotherapeutic agents have mechanisms in which a free radical is the active form of the treatment.
In order to test this concept of cross-resistance, we measured the ability of the A549-parent and A549-HHP cells to survive in various concentrations of doxorubicin (Fig. 7) . Even though these cells had not previously been exposed to doxorubicin, the A549-HHP cell line showed an enhanced ability to survive when treated with this chemotherapeutic agent. These findings imply that these adapted cells would be more resistant to any free-radical-based treatment, reflecting what is commonly found in the clinical setting.
In an effort to elucidate possible molecular mechanisms involved in the cross-resistance of the adapted cells, we compared the genome-wide expression of A549-parent and A549-HHP cell lines. As noted in Table 2 , which lists the ten most up-regulated and ten most down-regulated genes based on fold changes in gene expression found in the gene chip assay studies, there is a wide range of gene products involved in multiple pathways and various cellular components that are affected by the adaptation process. The diversity of gene types observed underscores the complexity of the gene milieu that is altered upon exposure to free radicals. This reflects the known biology of human tumors in that virtually every cellular system that has been studied to date has been found to have some level of abnormality when compared to normal cells. It also points to the fact that no one gene is responsible for all of the various alterations reported herein for the A549-HHP cell line when compared to the A549-parent cell line.
Mitochondria are a source of free radical production, and more so in an aerobic than anaerobic state. The "Warburg effect" is the observation that tumor cells predominately produce energy using glycolysis (anaerobic). Because of the importance of the "Warburg effect" in tumor biology, we question if the adaptation of the A549-parent cell line to H 2 O 2 would change the metabolic status of the adapted cells. We opined that such an adaptation would result in mitochondrial DNA being reduced and that the cells would move to a more anaerobic metabolic state. As noted in Fig. 8 , there was a statistically significant reduction (about 9-fold; P<0.05) in the copy number of mtDNA in the A549-HHP cell line when compared to the parent cell line. As a result of this reduction, it is implied that the cells have been adapted to a more anaerobic metabolic state. As a tumor grows in size, the cells are more likely to be in a hypoxic environment and therefore would have a growth advantage if they produced their energy primarily though glycolysis.
As noted above, it is an important finding that the adapted A549-HHP cell line had identical morphology to the A549-parent cell line. The significant cellular responses to the various conditions used herein on the A549-HHP cell line underscores what is seen in the clinic. Patients frequently present having morphologically identical tumors that behave and respond differently to various treatments. The model system developed herein, which uses H 2 O 2 as a way to alter the phenotypic expression of tumor cells, along with the previously reported model system which used DETA-NONOate, provides a means to study human tumor cells which reflect the spectrum of tumor types that present in the clinic. Future studies using both of these model systems will be directed at elucidating the mechanism(s) of how these aggressively growing adapted cells (utilizing two known physiologically relevant free radicals, NO
• and
• OH) are different from their less aggressive, nonadapted tumor cells. Understanding these mechanisms will provide new insights into how to treat aggressive tumor growth in patients. Fig. 8 Results of the qPCR analysis of mtDNA content (p<0.05)
